PRIMECAP Odyssey Aggressive Growth Fund
POAGX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 177 East Colorado Boulevard, 11th Floor Pasadena CA United States of America 91105
- IPO Date
- Nov 2, 2004
- CIK
- 0001293967
- Website
- primecap.com
- Similar Companies
- Business
- PRIMECAP Odyssey Aggressive Growth Fund (POAGX) is a mutual fund that seeks long-term capital appreciation by investing primarily in common stocks of U.S. companies with prospects for rapid earnings growth; it targets issuers across all market sectors and capitalizations, with a historical emphasis on mid- and small-cap stocks, and may include foreign securities via depository receipts or direct holdings. The fund employs a bottom-up fundamental research process to identify growth catalysts such as new products, markets, management changes, or industry shifts; it maintains sector overweight or underweight positions relative to the S&P 500 Index, holds approximately 193 stocks with a portfolio turnover of 10%, and features key metrics including a median market capitalization of $14.36 billion, forward P/E ratio of 22.1x, and sector allocations led by information technology (30.0%) and health care (25.0%). As of the latest data, net assets stand at $6.48-$6.83 billion, with a net expense ratio of 0.66%, a management fee of 0.55%, minimum initial investment of $2,000 ($1,000 for IRAs), and dividends/capital gains paid annually in December. Managed by PRIMECAP Management Company, founded in 1983 and headquartered at 225 South Lake Avenue, Suite 400, Pasadena, California, the fund follows the advisor's principles of individual decision-making, fundamental research, long-term horizons, and value focus; it launched on November 1, 2004 (CUSIP 74160Q202), operates in the U.S. market with primary exposure to domestic equities (84.5%), and serves retail and institutional investors seeking aggressive growth. PRIMECAP Management Company, an independent firm, also advises other Odyssey Funds and institutional separately managed accounts, with no reported parent company or major subsidiaries for the fund itself. In recent developments, PRIMECAP Management adjusted its broader strategies amid 2024-2025 market volatility, including a 17.76% reduction in its Eli Lilly stake in Q2 2025 as part of portfolio rebalancing while retaining 6.1% allocation to the stock and 21.5% overall healthcare exposure across funds; it added seven new stocks in Q3 2024 to optimize positions. The firm ended its longstanding asset-based fee arrangement with Vanguard PRIMECAP funds in early 2025, shifting from a simple percentage model that paid nearly $113 million in the prior six months. No major acquisitions, partnerships, funding rounds, name changes, or product launches specific to POAGX were reported in the last 1-2 years, with performance reflecting YTD returns of 27.12% and 1-year returns of 23.37% as of mid-2025.